<unk>  is a mouse anti-idiotype monoclonal antibody whose variable epitope mirrors a tumour antigen (CA-125) highly expressed in the epithelial ovarian cancer.<unk>  does not bind directly to CA-125, but it works as a "surrogate" antigen, enabling the immune system to identify and attack tumour cells displaying the CA 125 protein. Through this, it is hoped that the body's immune system may be able to combat any remaining individual tumour cells and thus prevent recurrence of the disease.
Abagovomab
Edrecolomab
Arcitumomab
Catumaxomab
Satumomab pendetide
Pemtumomab
Cemiplimab-rwlc
Tildrakizumab